|
|
|
|
| LEADER |
01701nam a2200373 4500 |
| 001 |
vtls000188118 |
| 003 |
RU-ToGU |
| 005 |
20210922004104.0 |
| 008 |
120827s2004 lu a f b i000 0 eng d |
| 020 |
|
|
|a 9291681822
|
| 022 |
|
|
|a 1725-4485
|
| 035 |
|
|
|a 0193-06560
|
| 039 |
|
9 |
|a 201208270403
|y 200511081109
|z Александр Эльверович Гилязов
|
| 040 |
|
|
|a RU-ToGU
|b eng
|c RU-ToGU
|e PSBO
|
| 080 |
|
|
|a 615.214
|
| 084 |
|
|
|a С550.8
|2 rubbk
|
| 245 |
1 |
0 |
|a Report on the risk assessment of TMA-2 in the framework of the joint action on new synthetic drugs
|c European monitoring centre for drugs and drug addiction
|
| 260 |
|
|
|a Luxembourg
|b Office for Official Publications of the European Communities
|c 2004
|9 702618
|
| 300 |
|
|
|a 74 p.
|
| 490 |
1 |
0 |
|a EMCDDA risk assessments
|v 7
|
| 504 |
|
|
|a References: p. 59-62
|
| 653 |
|
|
|a наркотики.
|
| 653 |
|
|
|a синтетические наркотики.
|
| 653 |
|
|
|a психическая зависимость.
|
| 653 |
|
|
|a наркотическая зависимость.
|
| 653 |
|
|
|a психическое здоровье.
|
| 653 |
|
|
|a наркотическое воздействие.
|
| 653 |
|
|
|a психофармакологические средства.
|
| 653 |
|
|
|a Европейский Союз.
|
| 830 |
|
|
|a EMCDDA risk assessments
|9 257916
|
| 852 |
4 |
|
|a RU-ToGU
|h С550.8
|i R44
|n ru
|
| 856 |
|
|
|y Перейти в каталог НБ ТГУ
|u https://koha.lib.tsu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=189933
|
| 999 |
|
|
|c 189933
|d 189933
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 2047246
|7 0
|9 350517
|a RU-ToGU
|b RU-ToGU
|c 10024
|d 2021-04-03
|g 350.00
|l 0
|o 2-047246
|p 13820000450829
|r 2024-02-05
|t 1
|w 2021-04-03
|y 1
|
